← Evidence map

RetractedArticleBlood2010

The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo.

Girija Dasmahapatra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

55 papers cite it

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 20233973